Page last updated: 2024-08-26

pyrimidin-2-one beta-ribofuranoside and Leukemia P388

pyrimidin-2-one beta-ribofuranoside has been researched along with Leukemia P388 in 1 studies

*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barchi, JJ; Driscoll, JS; Kelley, JA; Liu, PS; Marquez, VE; Plowman, J1

Other Studies

1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Leukemia P388

ArticleYear
Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Arabinonucleosides; Cytidine; Drug Screening Assays, Antitumor; Injections, Intraperitoneal; Injections, Subcutaneous; Leukemia L1210; Leukemia P388; Mice; Pyrimidine Nucleosides; Pyrimidinones; Structure-Activity Relationship

1991
chemdatabank.com